Amgen | DEBITO



Debt Cambiamento Data
AbbVie USD 69.89B 2.74B 2025-03
Agios Pharmaceuticals USD 48.76M 48.76M 2025-06
ALKERMES USD 72.68M 72.68M 2025-06
Amgen USD 57.38B 2.72B 2025-03
Biogen USD 6.59B 296.8M 2025-06
BioMarin Pharmaceutical USD 595.65M 585K 2025-03
Bristol-Myers Squibb USD 50.93B 1.22B 2025-06
Eli Lilly USD 38.52B 4.87B 2025-03
Exelixis USD 179.84M 179.84M 2025-06
Genmab DKK 143M 886M 2025-03
Gilead Sciences USD 24.95B 1.76B 2025-03
GlaxoSmithKline GBP 17.35B 1.08B 2025-06
Glaxosmithkline GBP 16.99B 927M 2024-12
Incyte USD 42.41M 5.29M 2025-06
Ionis Pharmaceuticals USD 1.42B 169.27M 2025-06
J&J USD 52.25B 15.62B 2025-03
Merck USD 34.84B 2.27B 2025-03
Moderna USD 741M 4M 2025-06
Neurocrine Biosciences USD 439.1M 8.4M 2025-06
Novartis USD 31.27B 12M 2025-03
Novartis USD 31.26B 828M 2024-12
Pfizer USD 62.11B 2.24B 2025-03
PTC Therapeutics USD 286.01M 2.12B 2025-06
Regeneron Pharmaceuticals USD 2.71B 300K 2025-06
Roche Holding CHF 34.44B 5.23B 2024-06
Sanofi 22.28B 1.24B 2025-06
Sarepta Therapeutics USD 1.14B 1.16M 2025-03
Takeda JPY 4.51T 9.32B 2025-06
Teva Pharmaceutical Industries USD 17.52B 872M 2025-06
Ultragenyx Pharmaceutical USD 38.27M 38.27M 2025-03
Vertex Pharmaceuticals USD 1.65B 1.54B 2025-03


Amgen DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.